gammabased - Share Your Cancer Stories | Cancer News & Awareness Updates

Browsing: gammabased

Research

Transcriptional intermediary factor 1 gamma-based multitarget gene therapeutic strategy for triple-negative breast cancer

By NewsCancerSeptember 29, 20260

Gene transfer of codon-optimized hTIF1γ into ex vivo-cultured biopsy tissues from TNBC patients suppresses EMT and proliferation while inducing apoptosis…

What's Hot

First-in-Human: Jyoti Malhotra, MD, MPH on Phase I Trials, Lung Cancer in 2026, and Yale

Fractionated SRS Should Be Standard of Care After Brain Metastasis Surgery

Transcriptional intermediary factor 1 gamma-based multitarget gene therapeutic strategy for triple-negative breast cancer

Browsing: gammabased

Transcriptional intermediary factor 1 gamma-based multitarget gene therapeutic strategy for triple-negative breast cancer

First-in-Human: Jyoti Malhotra, MD, MPH on Phase I Trials, Lung Cancer in 2026, and Yale

Fractionated SRS Should Be Standard of Care After Brain Metastasis Surgery

Transcriptional intermediary factor 1 gamma-based multitarget gene therapeutic strategy for triple-negative breast cancer

Hypofractionated PMRT Shows Durable 10-Year Control in High-Risk Breast Cancer

First-in-Human: Jyoti Malhotra, MD, MPH on Phase I Trials, Lung Cancer in 2026, and Yale

Fractionated SRS Should Be Standard of Care After Brain Metastasis Surgery

Transcriptional intermediary factor 1 gamma-based multitarget gene therapeutic strategy for triple-negative breast cancer

Hypofractionated PMRT Shows Durable 10-Year Control in High-Risk Breast Cancer

Latest Post

First-in-Human: Jyoti Malhotra, MD, MPH on Phase I Trials, Lung Cancer in 2026, and Yale

Fractionated SRS Should Be Standard of Care After Brain Metastasis Surgery

Transcriptional intermediary factor 1 gamma-based multitarget gene therapeutic strategy for triple-negative breast cancer

Subscribe to Updates

What's Hot

Browsing: gammabased